rxstat › Drug prices › Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba

Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba (Bexsero) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba 25 mcg/0.5ml / 50 mcg/0.5ml / 50 mcg/0.5ml / 50 mcg/0.5ml suspension costs about $125.70 per billed unit (often a pen or vial) on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. It is not a covered benefit on the public plans we track; the price shown is a list price.

Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formAB
25 mcg/0.5ml / 50 mcg/0.5ml / 50 mcg/0.5ml / 50 mcg/0.5ml Suspension$125.70/unitnot covered
Plan coverageNot covered

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 1 product
  • Bexsero 25 mcg/0.5ml / 50 mcg/0.5ml / 50 mcg/0.5ml / 50 mcg/0.5ml Suspension · NOV
    DIN 02417030 · $125.70/unit · Not covered

Price sources: Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
6

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
BEXSERO
25MCG 50MCG 50MCG 50MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02417030 · ended Feb 9, 2024 · Delay in shipping of the drug.
Resolved
BEXSERO
50MCG 50MCG 50MCG 25MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02417030 · ended Mar 21, 2019 · Disruption of the manufacture of the drug.
Resolved
BEXSERO
50MCG 50MCG 50MCG 25MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02417030 · ended Mar 19, 2019 · Disruption of the manufacture of the drug.
Resolved
BEXSERO
50MCG 50MCG 50MCG 25MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02417030 · ended Oct 29, 2018 · Demand increase for the drug.
Resolved
BEXSERO
50MCG 50MCG 50MCG 25MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02417030 · ended Sep 5, 2018 · Demand increase for the drug.
Resolved
BEXSERO
50MCG 50MCG 50MCG 25MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02417030 · ended Aug 7, 2018 · Demand increase for the drug.

What's happening

There are no active shortage reports for Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba. Health Canada has 6 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba is classified under “BACTERIAL VACCINES” (ATC J07AH).

Recent changes

Common questions

How much does Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba cost in Canada?

Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba 25 mcg/0.5ml / 50 mcg/0.5ml / 50 mcg/0.5ml / 50 mcg/0.5ml suspension costs about $125.70 per billed unit (often a pen or vial) on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. It is not a covered benefit on the public plans we track; the price shown is a list price.

Is Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba be back in stock in Canada?

Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba has no active shortage; supply is normal per Health Canada reports.

Why is Outer Membrane Vesicles Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Nada Nhba in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (bacterial vaccines)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.